Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole for Healing and Maintenance of Healed Erosive Esophagitis in Pediatric Subjects
NCT02615184Phase 2Terminated
- Sponsor
- Takeda
- Start
- May 2023
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of dexlansoprazole in erosive esophagitis (EE), sponsored by Takeda. Started May 2023; status: terminated.
02
Drugs
dexlansoprazole
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT02615184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02615184.